Voyage
Pet parentsVets
DispatchJoinGet free access

Veterinary Clinical Reference

Look up any drug or condition.

Evergreen, evidence-based hubs on the drugs, conditions, and species you manage — continuously updated and cited at every claim.

/
306 evergreen hubsCited at every claimContinuously updatedFree for verified vets
All (306)Pain & Osteoarthritis (9)Dermatology & Allergy (14)Cardiology (5)Respiratory & Emergency (6)Neurology & Epilepsy (14)Endocrinology (7)GI & Appetite (18)Infectious Disease (5)Nephrology & Urology (4)Ophthalmology (7)Behavior (12)Immunology & Oncology (3)Toxicology & Emergency (23)Exotic & Zoological (164)
All species (3)Dogs & Cats (2)Canine (1)
CanineJun 5, 2026

Verdinexor (Laverdia) for Canine Lymphoma: Mechanism and Evidence

Verdinexor (Laverdia-CA1), an oral XPO1/nuclear-export inhibitor for canine lymphoma: mechanism, an 8-dog cutaneous T-cell pilot, and combination data.

Read →

Voyage surfaces cited veterinary evidence to inform your clinical judgment — never to replace it. Always confirm dosing and treatment against current formularies.

Built for pets. Not repurposed from humans.

Built by Voyage